RHEUMASTAT
Live / Applied — Second extension granted (statement of use) (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 17 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99087508
- Mark type
- Stylized text
- Filed
- 17 Mar 2025
- Published for opposition
- 05 Aug 2025
- Attorney of record
- Leslie C. Vander Griend
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids.
Owner
- Augurex Life Sciences Corp., Vancouver, BC, CA
- Augurex Life Sciences Corp., Vancouver, BC, CA
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2026 — SOU EXTENSION 2 GRANTED
- 09 Sept 2026 — SOU EXTENSION 2 FILED
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2026 — SOU EXTENSION 1 GRANTED
- 02 Mar 2026 — SOU EXTENSION 1 FILED
- 15 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Aug 2025 — PUBLISHED FOR OPPOSITION
- 30 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jun 2025 — ASSIGNED TO EXAMINER